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QUANTITATIVE MRI ASSESSMENT OF THE
PROGRESSION OF KNEE STRUCTURAL CHANGES IN
AN OSTEOARTHRITIS EXPERIMENTAL DOG MODEL:
CORRELATION WITH MACROSCOPIC FINDINGS
C. Boileau1, J. Martel-Pelletier1, F. Abram2, J-P. Raynauld1,
É. Troncy3, M-A. D’Anjou3, M. Moreau3, J-P. Pelletier1
1Osteoarthritis Research Unit, University of Montreal Hospital
Centre, Notre-Dame Hospital, Montreal, PQ, Canada;
2ArthroVision Inc., Montreal, PQ, Canada; 3Companion Animal
Research Group, Veterinary Teaching Hospital Centre,
University of Montreal, St-Hyacinthe, PQ, Canada
Purpose: Animal models have been used extensively to study
the pathophysiology of osteoarthritis (OA). Among them the ante-
rior cruciate ligament (ACL) dog model demonstrates the ability
to reproduce morphological and molecular changes of human
OA, and have been very useful for testing the effects of disease-
modifying osteoarthritis drugs (DMOAD). Magnetic resonance
imaging (MRI) technology provides precise and reliable quan-
titative information on joint tissue structure and changes over
time. Here, we investigated the reliability of quantitative MRI in
assessing OA joint structural changes in the ACL experimental
dog model over a period of 26 weeks.
Methods: OA was surgically induced by transection of the ACL
of the right knee (n=5). High resolution 3D MRI using a 1.5
T magnet was performed on the right knee at baseline, 4, 8
and 26 weeks post-surgery. Cartilage volume/thickness, cartilage
defects, osteophyte formation and subchondral bone lesions
(hypersignal) were assessed on MR images in the whole knee
as well as on the different anatomical subregions of the knee. The
dogs were sacriﬁced at week 26 and macroscopic evaluation of
the knee cartilage lesions and osteophyte size were performed.
Statistical analysis comparing values obtained at 4, 8 and 26
weeks to baseline was done by ANOVA followed by Tukey’s
multiple comparison test.
Results: Quantitative MRI analysis showed a progressive and
signiﬁcant increase in the loss of knee OA cartilage volume over
time (from -14.9±1.9%, P<0.001 at 4 weeks to -29.0±3.6%,
P<0.001 at 26 weeks), of incidence and size of cartilage defect
(from 1.31±0.28, P<0.001 to 3.23±0.12, P<0.001) and of sub-
chondral bone hypersignal (from 0.6±1.0 to 1.7±0.3, P<0.001).
The osteophyte size also progressed over time (from 4.8±0.8
mm, P<0.01 to 12.1±1.4 mm, P<0.001). Subregional analy-
sis revealed that the greatest cartilage volume loss was found
predominantly on the tibial plateaus and in the medial compart-
ment (medial femoral condyle and tibial plateau). There were
highly signiﬁcant correlations between cartilage loss or defect
and subchondral bone hypersignal (r=-0.81; r=0.75, both at a
P<0.0001). These ﬁndings from MRI correlated very well with
the macroscopic evaluation of cartilage lesions and osteophytes
26 weeks post-surgery.
Conclusions: This study demonstrated that MRI provides a
non-invasive and reliable quantitative assessment of the joint
structural changes during the development of OA in the ACL dog
model. The combination of this OA model with MRI evaluation
provides a powerful tool for the evaluation of the effectiveness of
new DMOADs.
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THE ROLE OF SOX9 IN JOINT FORMATION
S.P. Henry, L. Zhang, B. De Crombrugghe
University of Texas MD Anderson Cancer Center, Houston, TX
Purpose: The major goal of this study is to examine the function
of the transcription factor Sox9 in joint development and joint
homeostasis.
Methods: To study the role of Sox9 in joint formation, we have
obtained a transgenic driver mouse that expresses cre recombi-
nase in the developing joint called gdf5-cre and have bred this
mouse to a mouse containing a conditional Sox9 allele ﬂanked
by loxP sites (Sox9 ﬂox/ﬂox) in order to generate Sox9ﬂox/ﬂox:
gdf5-cre mice, in which the Sox9 gene should be inactivated in
the presumptive, developing joint.
Results: To our surprise, all mutant mice, Sox9ﬂox/ﬂox: gdf5-cre,
die at birth due to a diaphragmatic hernia and display shortened
forelimbs and hindlimbs. Some mutant mice die in utero be-
tween 15.5 and 16.5 days post coitum (dpc) due to massive
internal hemorrhaging caused by a complete lack of a sternum
(sternebrae are not formed) and a dramatically smaller rib cage.
However, a consistent phenotype observed amongst all mutant
animals is the bending of the ulna and humerus in the arm. In
many cases, the radius and humerus are fused at the elbow
joint,similar to the phenotype previously reported in the Noggin
null mice. In Sox9 mutants of strong penetrance, a complete lack
of interdigital joints is evident at 16.5 days post coitum. We are
currently performing RNA in situ hybridization experiments in the
mutant mice joints to analyze the expression of genes implicated
in joint formation; namely, gdf5, noggin, wnt9a, and sfrp-2. In
many mutants, gdf5 mRNA is not detected at the joint interzone
but rather is mislocalized to the cells surrounding the cartilage
anlagen in the digits at 13.5 dpc mutants. Further characteriza-
tion of Sox9ﬂox/ﬂox: gdf5-cre mutant mice should help delineate
the role of Sox 9 in joint formation.
Conclusions: The transcription Sox9 is essential for normal joint
formation. By inactivating the mouse Sox9 gene with a transgenic
gdf5-cre driver mouse, bony joint fusions are evident between
the radius and the humerus at 16.5 dpc. Furthermore, a com-
plete lack of interphalangeal joints is apparent in Sox9 mutants
of strong penetrance. The missing interphalangeal joints may
be caused by the mislocalization of the gdf5 mRNA from its
normal expression at the joint interzone to the outlying cells sur-
rounding the cartilage anlagen at 13.5 dpc of mouse embryonic
development.
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ORAL CALCITONIN PROTECTS AGAINST CARTILAGE
EROSION IN AN EXPERIMENTAL MODEL OF
OSTEOARTHRITIS
R.H. Nielsen, B-C. Sondergaard, C. Christiansen, M.A. Karsdal
Nordic Bioscience, Herlev, Denmark
Purpose: Osteoarthritis (OA) is a disease that affects the entire
articular joint. The optimal treatment would target both bone and
cartilage. Calcitonin has been shown to affect both osteoclasts
and chondrocytes. We investigated whether a novel oral for-
mulation of salmon calcitonin could attenuate cartilage damage
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observed secondary to traumatic induction of OA by anterior
cruciate ligament transection (ACLT).
Methods: Four groups of 10 female rats were subjected to ei-
ther sham or ACLT surgery in both knee joints and administered
twice a day for 28 days with an oral dose of salmon calci-
tonin (150mg/kg 5-CNAC + 2mg/kg calcitonin) or vehicle control
(150mg/kg 5-CNAC). Serum samples were collected at baseline
and 7, 14, 21 and 28 days and weights were recorded at reg-
ular intervals. Cartilage degradation was evaluated in serum by
C-terminal telopeptide of type II collagen (CTX-II ELISA). Knee
joints were collected at euthanasia and one was processed
for histology and immunohistochemistry (IHC). Sections were
scored on a modiﬁed Mankin score for proteoglycan content,
chondrocytes cloning and cartilage erosion on a scale from 0-4,
where the score 4 was most severe damage. Immunolocalization
of antibodies towards CTX-II fragments, MMP-13 expression and
proliferation (Ki67) was visualized by IHC.
Results: Treatment with salmon calcitonin signiﬁcantly reduced
serum CTX-II levels in sham+calcitonin animals on day 14 (52%,
P<0.05) and day 28 (49%, P<0.001), compared to the con-
trol group. Treatment with calcitonin also reduced CTX-II levels
in the ACLT+calcitonin groups on day 14 (50%, P<0.01) and
day 28 (41%, P<0.05), compared to the control group. ACLT
operated knees resulted in a 40% signiﬁcant (P<0.001) in-
crease in total Mankin score. Calcitonin restored Mankin score
to below sham levels, (P<0.05). The most promising effect was
observed on cartilage erosion. MMP-13 expression and CTX-II
fragments were co-localized in the articular cartilage surface in
the eroded areas. Serum CTX-I levels decreased in calcitonin
treated animals compared to sham operated animals (36%,
P<0.001).
Conclusions: Currently there are no treatments available for
OA. Calcitonin has recently been proposed as a potential treat-
ment for OA. These data are the ﬁrst to demonstrate that an oral
formulation of calcitonin protect against cartilage degradation in
an in vivo model of joint trauma and increased cartilage degra-
dation. The chondroprotective effect of salmon calcitonin may
be a combination of direct effects on chondrocytes in addition
to the well-established effect on bone resorption. Further clinical
studies are needed to validate the herein documented effects on
cartilage erosion.
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GAIT AS A SURROGATE MEASURE OF PAIN/DISABILITY
IN ADDITION TO STRUCTURAL PARAMETERS OF JOINT
DAMAGE AND INFLAMMATION IN TWO DIFFERENT
CANINE MODELS OF OA
S.C. Mastbergen1, L.N. Frost-Christensen2, H.A. Hazewinkel2,
F.P. Lafeber1
1Rheumatology & Clinical Immunology, University Medical
Center Utrecht, Utrecht, The Netherlands; 2Department of
Clinical Sciences of Companion Animals, Faculty of Veterinary
Medicine, Utrecht University, Utrecht, The Netherlands
Purpose: The most frequently used model for osteoarthritis (OA)
is the canine joint instability, viz. ACLT, model. The ACLT model
can be extended with a medial meniscectomy (i.e., ACLT-Mx
model) to avoid unintentional, and with that variable, meniscal
damage. More recently the canine Groove model has been
developed in which OA is caused by surgically induced cartilage
damage combined with temporary intermittent forced loading of
the joint. Both models demonstrated comparable development
of cartilage damage but they have never been compared on
changes in gait as measure of pain/disability. Such a clinical
measure is, in addition to structural parameters of joint damage
and inﬂammation, of major importance in evaluation of treatment
strategies of OA.
Methods: Knee osteoarthritis (OA) was induced in Labrador
dogs according to the ACLT-Mx model (n=7) or Groove model
(n=7). Every four weeks standardized radiographs were taken
to analyze osteophyte formation. Every two weeks gait was
recorded using Force Plate Analysis (FPA). Joints were macro-
scopic, histological, and biochemical analyzed for features of OA,
12 weeks after induction of OA.
Results: Radiographs revealed osteophyte formation in the ex-
perimental joints at the expected locations and the overall os-
teophyte score increased signiﬁcantly (p<0.05) over time for
both models. Cartilage integrity was damaged as reﬂected by
an increased macroscopic ( 1.5 vs. 1), and histological score
( 3 vs. 2.5) and a decreased proteoglycan content (-29% vs.
-18%) for the ACLT-Mx model and Groove model, respectively
(all p<0.05). Chondrocyte activity demonstrated an increased
synthesis rate (+70% vs. +10%) and release of proteoglycans
(+200% vs. +60%) for the ACLT-Mx model and Groove model,
respectively (both p<0.05). Synovial inﬂammation revealed the
same characteristics in both models ( 3.5 vs. 1.0 and 1.2 vs. 0.8
for macroscopic and histological inﬂammation in the, ACLT-Mx vs.
Groove model, respectively). Gait analysis revealed, a decrease
in the three peak ground reaction forces of the experimental leg
after OA induction (p<0.05), ranging from -80% in the ACLT-MX
model to -40% in groove model, statistically different between
both models (p<0.05). On average the ACLT-Mx demonstrated
more pronounced changes compared to the Groove model. In-
terestingly, the change in gait (all three ground reaction forces)
correlated signiﬁcantly with the change in cartilage integrity (pro-
teoglycan content and histological grade; r=0.445, r=0.488, and
r=0.542 for peak braking, stance, and propelling force, respec-
tively; all p<0.003).
Conclusions: The ACLT-Mx model demonstrates all the charac-
teristics of OA and can be designated as a moderate to severe
model of OA with clear synovial inﬂammatory activity. The Groove
model is a less painful and signiﬁcantly milder model of OA. The
latter might be more suitable to study subtle changes as a result
of intervention than the more robust ACLT-Mx model. Moreover,
gait might be used as a surrogate measure of pain/disability.
Most important, degree of cartilage damage is reﬂected by the
extent to which the OA joint was (un)loaded.
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TIBIAL CARTILAGE SURFACE AREA, THICKNESS AND
VOLUME IN VARIOUS ANIMAL SPECIES AND IN
HUMANS
B. Wehr1, A. Grams1, M. Hudelmaier2, J. Kotyk3,
L. Wachsmuth4, F. Eckstein2
1Chondrometrics GmbH, Ainring, Germany; 2Paracelsus
Medical University, Salzburg, Austria; 3Washington University
School of Medicine, St Louis, MO; 4University of Erlangen,
Erlangen, Germany
Purpose: Appropriate dosage of intra-articular injections of
drugs with potentially beneﬁcial structural or symptomatic ef-
fects on articular cartilage requires information on the cartilage
surface area, and potentially, on the cartilage thickness and vol-
ume. As various animal models are used to test the effect of
such drugs in preclinical models, the aim of the current study
was to provide quantitative, three-dimensional data on the tibial
cartilage surface areas, cartilage thickness and cartilage volume
in a variety of animal species and in humans.
Methods: The knees of 16 male Sprague Dawley rats (body
weight 300 g) and 6 rabbits (weight 3.5 kg) were investigated
with magnetic resonance imaging at 7 Tesla (T), and the knees
and the knees of 3 cats (weight 4.2 kg), 18 mongrel dogs (weight
25 kg), 1 pig (weight 110 kg), 1 horse (weight 535 kg) and 1
rhinoceros (weight 1200 kg) at 1.5T. The values were compared
